Dunn KE - Search Results

1

Impacts of xylazine on fentanyl demand, body weight, and acute withdrawal in rats: A comparison to lofexidine.

Sadek SM, Khatri SN, Kipp Z, Dunn KE, Beckmann JS, Stoops WW, Hinds TD Jr, Gipson CD. Sadek SM, et al. Among authors: dunn ke. Neuropharmacology. 2024 Mar 1;245:109816. doi: 10.1016/j.neuropharm.2023.109816. Epub 2023 Dec 20. Neuropharmacology. 2024. PMID: 38128606 Free article.

2

Non-Opioid Neurotransmitter Systems that Contribute to the Opioid Withdrawal Syndrome: A Review of Preclinical and Human Evidence.

Dunn KE, Huhn AS, Bergeria CL, Gipson CD, Weerts EM. Dunn KE, et al. J Pharmacol Exp Ther. 2019 Nov;371(2):422-452. doi: 10.1124/jpet.119.258004. Epub 2019 Aug 7. J Pharmacol Exp Ther. 2019. PMID: 31391211 Free PMC article. Review.

3

Establishing preclinical withdrawal syndrome symptomatology following heroin self-administration in male and female rats.

Gipson CD, Dunn KE, Bull A, Ulangkaya H, Hossain A. Gipson CD, et al. Among authors: dunn ke. Exp Clin Psychopharmacol. 2021 Dec;29(6):636-649. doi: 10.1037/pha0000375. Epub 2020 Apr 16. Exp Clin Psychopharmacol. 2021. PMID: 32297787 Free PMC article.

4

The continued rise of methamphetamine use among people who use heroin in the United States.

Strickland JC, Stoops WW, Dunn KE, Smith KE, Havens JR. Strickland JC, et al. Among authors: dunn ke. Drug Alcohol Depend. 2021 Aug 1;225:108750. doi: 10.1016/j.drugalcdep.2021.108750. Epub 2021 May 21. Drug Alcohol Depend. 2021. PMID: 34052690 Free PMC article.

5

Dopamine Supersensitivity: A Novel Hypothesis of Opioid-Induced Neurobiological Mechanisms Underlying Opioid-Stimulant Co-use and Opioid Relapse.

Strickland JC, Gipson CD, Dunn KE. Strickland JC, et al. Among authors: dunn ke. Front Psychiatry. 2022 Apr 15;13:835816. doi: 10.3389/fpsyt.2022.835816. eCollection 2022. Front Psychiatry. 2022. PMID: 35492733 Free PMC article. Review.

6

Xylazine suppresses fentanyl consumption during self-administration and induces a unique sex-specific withdrawal syndrome that is not altered by naloxone in rats.

Khatri SN, Sadek S, Kendrick PT, Bondy EO, Hong M, Pauss S, Luo D, Prisinzano TE, Dunn KE, Marusich JA, Beckmann JS, Hinds TD, Gipson CD. Khatri SN, et al. Among authors: dunn ke. Exp Clin Psychopharmacol. 2024 Apr;32(2):150-157. doi: 10.1037/pha0000670. Epub 2023 Jul 20. Exp Clin Psychopharmacol. 2024. PMID: 37470999

7

Knowledge, Preference, and Adverse Effects of Xylazine Among Adults in Substance Use Treatment.

Hochheimer M, Strickland JC, Rabinowitz JA, Ellis JD, Dunn KE, Huhn AS. Hochheimer M, et al. Among authors: dunn ke. JAMA Netw Open. 2024 Feb 5;7(2):e240572. doi: 10.1001/jamanetworkopen.2024.0572. JAMA Netw Open. 2024. PMID: 38416493 Free PMC article.

8

Establishing a research agenda for the study and assessment of opioid withdrawal.

Dunn KE, Strain EC. Dunn KE, et al. Lancet Psychiatry. 2024 Jul;11(7):566-572. doi: 10.1016/S2215-0366(24)00068-3. Epub 2024 Mar 20. Lancet Psychiatry. 2024. PMID: 38521089 Review.

9

Examining the Severity and Progression of Illicitly Manufactured Fentanyl Withdrawal: A Quasi-Experimental Comparison.

Sharma A, Dunn KE, Schmid-Doyle K, Dowell S, Kim N, Strain EC, Bergeria C. Sharma A, et al. Among authors: dunn ke. J Addict Med. 2024 Nov 26. doi: 10.1097/ADM.0000000000001395. Online ahead of print. J Addict Med. 2024. PMID: 39591629

10

Characterizing opioid withdrawal during double-blind buprenorphine detoxification.

Dunn KE, Saulsgiver KA, Miller ME, Nuzzo PA, Sigmon SC. Dunn KE, et al. Drug Alcohol Depend. 2015 Jun 1;151:47-55. doi: 10.1016/j.drugalcdep.2015.02.033. Epub 2015 Mar 12. Drug Alcohol Depend. 2015. PMID: 25823907 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

179 results

Search Page

Filters